Experience. Integrity. IMPACT.
What We Do
Author Archives: Elaina Howard

Tips for Effective Meetings – Getting the Most out of the Time Spent Together

December 20, 2017 | Elaina Howard, PhD, RAC, Senior Manager, Medical Writing and Submissions Management | Medical Writing Services

Have you recently tried to schedule a meeting with your coworkers and found it difficult to find a time when everyone is available? If this is the case, then you know how precious the time together can be and how important it is to have effective and efficient meetings.

To put time spent in meetings into perspective, I often remind myself that while in a meeting, you are really using that time spent multiplied by the number of people in the room. That can be a lot of pressure to make good use of this time!

Not to worry, though; in this blog post, I’m going to suggest general meeting efficiency tips and I will also detail how I aim to get the most out of two common types of meetings for regulatory medical writers.

Continue reading

Warning Letters for Misguided Online Direct-To-Consumer Ads and the Age Old Question, “OMG. Have you heard about this?”

September 24, 2015 | Elaina Howard, PhD, RAC, Clinical Research Scientist II | Regulatory Affairs


Image courtesy of www.pharmpro.com

In my last blog post detailing direct-to-consumer (DTC) advertising in the age of social media, I briefly summarized the draft guidances for online DTC advertising activities.

In this post, I’ve provided a quick rundown of another great source of information about the FDA’s current thinking; the FDA warning letters that have been issued in response to some unfortunately misguided online DTC ads.

Continue reading

Direct-to-Consumer (DTC) Advertising in the Age of the Internet and Social Media

August 26, 2015 | Elaina Howard, PhD, Clinical Research Scientist II | Regulatory Affairs

More and more consumers are turning to online platforms to get information about all types of products, and as such, pharmaceutical companies have turned to online advertising of their products.

Because the internet and social media are becoming increasingly popular outlets for direct-to-consumer (DTC) advertising of prescription drugs, the FDA has established regulatory guidelines for this type of advertising by pharmaceutical and biotechnology companies.

Continue reading

IMPACT Pharmaceutical Services Announces Launch of Updated Website at www.impactpharma.com

May 29, 2014 | Elaina Howard, PhD, RAC, Clinical Research Scientist II

IMPACT Pharmaceutical Services announces launch of updated website at www.impactpharma.com.

IMPACT’s website is redesigned with a fresh, clean look to highlight its new service offerings, including electronic publishing, and to provide updated information about its established services, including medical writing and quality control, drug development consulting, regulatory affairs, project/program management, and early phase clinical trial management.

The new website includes added features that allow a client or prospective client to submit a request for a proposal or ask a question of one of IMPACT’s drug development experts.  Also available on the updated website are case studies that highlight the types of projects IMPACT gets involved with and what its clients have to say about IMPACT.  While IMPACT’s website has a new look, the company’s objectives and core values have not changed.

Continue reading